Hashemi, M. M.; Rovig, J.; Bateman, J.; Holden, B. S.; Modzelewski, T.; Gueorguieva, I.; von Dyck, M.; Bracken, R.; Genberg, C.; Deng, S.; Savage, P. B. J. Antimicrob. Chemother. 2017, in press. Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic.
Hashemi, M. M.; Rovig, J.; Weber, S.; Hilton, B.; Forouzan, M. M.; Savage, P. B. Antimicrob. Agents Chemother. 2017, 61, e00292-17. Susceptibility of colistin-resistant, Gram-negative bacteria to antimicrobial peptides and ceragenins.
Polonskaya, Z.; Deng, S.; Sarka, A.; Kain, L.; Comellas-Aragones, M.; McKay, C.; Kaczanowska, K.; Holt, M.; McBride, R.; Palomo, V.; Self, K.; Taylor, S.; Irimia, A.; Mehta, S. R.; Dan, J. M.; Brigger, M.; Crotty, S.; Schoenberger, S. P.; Paulson, J. C.; Wilson, I. A.; Savage, P. B.; Finn, M. G.; Teyton, L. J. Clin. Invest. 2017, 127, 1491-1504. Nanomolar affinity anti-glycan antibody generation is controlled by T cells.
Deng, S.; Kain, L.; Pereira, C. S.; Mata, S.; Macedo, M. F.; Bendelac, A.; Teyton, L.; Savage, P. B. Chem. Sci. 2017, 8, 2204-2208. Psychosine variants as antigens for natural killer T cells.
Kain, L.; Webb, B.; Anderson, B. L.; Deng, S.; Holt, M.; Castanzo, A.; Zhao, M.; Self, K.; Teyton, A.; Everett, C.; Kronenberg, M.; Zajonc, D. M.; Bendelac, A.; Savage, P. B. Teyton, L. Immunity 2014, 41, 543-554. The identification of the endogenous ligands of natural killer T cells reveals the existence of mammalian alpha-linked glycosylceramides.
Nitcheu, J.; Crabé, S.; Orlandini, B.; Nell, H.; Grygar, C.; Bellier, F.; Racouet, F.; Bendelac, A.; Deng, S.; Savage, P. B.; Teyton, L.; Serra, V. Vaccine 2014, 32, 6138-6145. Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.
See complete list
